Maack, Christoph https://orcid.org/0000-0003-3694-4559
Article History
First Online: 22 June 2025
Competing interests
: C.M. is an advisory board member or speaker for Amgen, AstraZeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Edwards, Lilly, Novartis, Novo Nordisk and Servier.